Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis

Zhang, D., Newton, C. A., Wang, B., Povysil, G., Noth, I., Martinez, F. J., Raghu, G., Goldstein, D., & Garcia, C. K. (2022). Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. European Respiratory Journal, 60(6), 2200577. https://doi.org/10.1183/13993003.00577-2022

Authors:

David Zhang

Chad A Newton

Binhan Wang

Gundula Povysil

Imre Noth

Fernando J Martinez

Ganesh Raghu

David Goldstein

Christine Kim Garcia

Affiliated Authors:

David Zhang